Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
BeerIsGood'
Thats a cool heating system you have there, will it heat up a ham&cheese empanadas? You might have to modify it a bit to reheat the cones. I think CONZ might be interested if you have a patient.
Imaging3’s CEO, Dean Janes, conducted a Conference Call on Monday, May 21, 2012 at 2:00pm Pacific Daylight Time. During the call, Mr. Janes updated Shareholders and other interested parties of the current developments with the company. The announcement was followed by an extensive question and answer session. The audio recording is now available on the company’s website, www.imaging3.com.
Sincerely,
Imaging3, Inc.
Burbank CA 91505
(800) 900-9729
info@imaging3.com
www.imaging3.com
Safe Harbor Statement
Matters discussed in this press release contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. When used in this press release, the words "anticipate," "believe," "estimate," "may," "intend," "expect" and similar expressions identify such forward-looking statements. Actual results, performance or achievements could differ materially from those contemplated, expressed or implied by the forward-looking statements contained herein. These forward-looking statements are based largely on the expectations of the Company and are subject to a number of risks and uncertainties. These include, but are not limited to, risks and uncertainties associated with: the impact of economic, competitive and other factors affecting the Company and its operations, markets, product, and distributor performance, technological obsolescence, competition from other medical instrument(s) and imaging companies, lack of capital, unexpected costs, failure or delay of FDA approval, absence of revenue, the impact on the national and local economies resulting from an economic recession or terrorist actions, and U.S. actions subsequently; unavailability of financing for the Company or its customers, product malfunction and potential product liability claims, and other factors detailed in reports filed by the Company.
We apologize for any inconvenience. If you would like to be removed from this mailing list, please reply to this email with the subject line “Unsubscribe”. Thank you.
Quote
Dean had the nerve to face his accusers in yesterday's conference call... problem is... none of his accusers had the nerve to show up and face him. Might have been interesting dontcha think?
No, the interesting part is yet to come. His accusers have contacted the proper authorities. This is the proper way to handle the situation. Not confront him personally. This is why the United States has Federal Oversight such as the Securities Exchange Commission. They have experienced people to investigate and find the truth, whatever it may be.
Your moniker implies you would handle the situation in the same manner.
There would be a huge contingent of gambling bagholders putting out word that the announcement was simply a ploy by management to take the company private on the cheap.
Thats a new one. I wouldnt worry about the booYa board or the vote count. Im sure someone is looking into it ;)
He wasent even sure what the dilution was from the toxic lenders 250-300 million? I bet he knows exactly what the number is. He also knew the next one would be 66 million shares..... he was cherry picking what he wanted to remember.... sounded like that attorney he spoke of during the call was close by?
Wouldn't be a bit surprised to see a SEC filing for an event over a year old.
It seems any information the shareholders get via SEC filing trickle out, and are always way after they have occurred. There have been so many examples of this; Chris Sohn selling his shares during the buyback is just one example in addition to the most recent filings on Dean shares and the lawsuits with the lenders. What Next
Flash
Can't get around that. The last financing Dean disclosed he borrowed some money and pledged 15 million shares against the loan and they MIGHT be sold.
Turns out this happened in 2009, that is was 38 million and not 15 million, and the shares WERE SOLD.
It could be worse than we think, Could be 2 seperate loans!! for a total of 53 million shares?
Now is the time for the shareholders from this board to ask the hard questions we have discussed in the past. Yes you, me and everyone else that has posted here over the last 2 years. STEP UP and dial the PHONE."please call 1-888-205-6786,enter passcode 161478 followed by the pound sign (#). You will be connected to the conference call in a listen only mode, and then lines will be opened for questions following the presentation."
http://www.imaging3.com/news/pressreleases/press_may17_12.html
I’m looking forward to Mondays call. We can hear it right from Dean what the game plan is for Imaging 3, where the company stands now, and how Imaging 3 plans on going forward from here.
I must commend Dean on having a set of Balls; I honestly never thought he would give investors another chance to ask question again, after the NSE.
I only have one question for Dean Janes? What is the Outstanding Shares count after all the deals that have transpired? I have lost track; this is not a slam, but an honest question. Hopefully he can address this question with the true number and exceptions or circumstances to come with the nuances of each deal on the share count, even after reading all the filings.
Hopefully ASCO will reveal some good news! Going to have a few myself this afternoon. Have a good weekend all.
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
During the three month period ended March 31, 2012, the Company issued 10,403,362 of common stock for $200,000 dollars.
During the three month period ended March 31, 2012, the Company issued 500,000 of common stock for $37,500 dollars for services rendered.
On or about March 28, 2012, the Company issued 8,403,362 shares of its common stock pursuant to the cash exercise of 8,403,362 Series A Warrants, for which the Company received $100,000 of capital.
We recently settled a lawsuit on terms that will cause the substantial dilution of our outstanding common stock, and we may in the future be subject to other litigation . On November 29, 2011, we were served with a Motion to Compel Arbitration by Cranshire Capital, LLC (the “Plaintiff” or “Cranshire”), one of two Warrant holders with whom we completed a private placement for the sale of common stock and warrants for $1,000,000 in October 2010. The Plaintiff alleged that it and Freestone Advantage Partners, L.P. are the holders of Series A Warrants, Series B Warrants and Series C Warrants (collectively, the “Warrants”) and that our entry into a transaction in October 2011 had the effect of triggering the anti-dilution provision in the Warrants. They alleged that the effect of the application of the anti-dilution provisions was to substantially lower the exercise price of the Warrants and increase the number of them. We believe that we had meritorious defenses to the Plaintiff’s claims. Nevertheless, the parties have agreed to settle the claims. Accordingly, on or about March 28, 2012, we entered into a Claims Exchange Agreement (the “Cranshire Agreement”) with Cranshire and a Settlement Agreement (the “Freestone Agreement”) with Freestone Advantage Partners, L.P. (“Freestone”), the other holder of Warrants, in order to settle the disputes between us and Cranshire and us and Freestone. Pursuant to the Cranshire Agreement, we and Cranshire have agreed that as a result of the issuance of securities by us pursuant to the transaction in October 2011, Cranshire is entitled to (i) an exercise price under each of Cranshire’s Warrants of $0.0119 per share, and (ii) the following as a result thereof: (a) 103,466,396.17 shares of our common stock issuable upon exercise of Cranshire’s Series A Warrant, (b) 22,868,151.26 shares of our common stock issuable upon exercise of Cranshire’s Series B Warrant and (c) 103,466,396.17 shares of common stock issuable upon exercise of Cranshire’s Series C Warrant. Cranshire also agreed that its Series B Warrant will terminate and be cancelled simultaneously with the occurrence of the closing under the Cranshire Agreement, and we will have no further obligation to deliver any shares of our common stock under Cranshire’s Series B Warrant. Pursuant to the Freestone Agreement, we and Freestone have agreed that as a result of the issuance of securities by the Company pursuant to the transaction in October 2011, Freestone is entitled to (i) an exercise price under each of Freestone’s Warrants of $0.0119 per share, and (ii) the following as a result thereof: (a) 1,575,645.38 shares of our common stock issuable upon exercise of Freestone’s Series A Warrant, (b) 1,260,516.30 shares of our common stock issuable upon exercise of Freestone’s Series B Warrant, and (c) 1,575,645.38 shares of common stock issuable upon exercise of Freestone’s Series C Warrant. Freestone also agreed that its Series B Warrant will terminate and be cancelled simultaneously with the occurrence of the closing under the Cranshire Agreement, and we will have no further obligation to deliver any shares of our common stock under Freestone’s Series B Warrant. Since March 28, 2012, the date of the settlement agreements, Cranshire and Freestone have exercised a total of 28,677,221 Series A Warrants, 8,403,362 of which were exercised on a cash basis for an aggregate exercise price of $100,000 and the issuance of 8,403,362 shares of our common stock, and 20,273,859 of which were exercised on a cashless basis, resulting in the issuance of a total of 12,271,178 shares of our common stock. Our shareholders could incur additional dilution in their ownership of us as a result of the full ratchet anti-dilution provisions of other outstanding convertible securities that may be triggered by the adjustments made in the settlement. Additionally, we cannot assure that future litigation in which we may become involved will not have a material adverse effect on our financial condition, operating results, business performance and business reputation. Investors who purchase shares of our common stock will be subject to the risk of total loss if the risks described herein are realized, because there may be insufficient assets with which to pay our debts, leaving shareholders with no recovery.
Conference Call Monday
Imaging3™, Inc. (OTCBB: IMGG), developer of a breakthrough medical imaging device that produces 3D medical diagnostic images of virtually any part of the human body in real-time, announced that at 2:00pm PDT (5:00pm EDT), Monday, May 21st, 2012, the company's CEO, Mr. Dean Janes, will be hosting a conference call. To join the conference call, please call 1-888-205-6786 and enter passcode 161478 followed by the pound sign (#). You will be connected to the conference call in a listen only mode, and then lines will be opened for questions following the presentation.
I now have a stronger suspicion than ever of a hostal takeover attempt.
I think your forgetting the high percentage of Inst. Ownership of this company.
If an offer were tabled, I believe it will come after Pona NDA is filed.
If an offer was to be made, I think they would make their best offer first, it won’t be a hostile takeover bid IMO.
Just my .02
I was speaking to a friend about this today. It will be some time in the future after they become profitable, but I may leave my 10% I saved as long term trade taxes invested in ARIA. I think Ariad stands a good chance of becoming a stand alone company in the future.
Its not over until COB Friday, anything can happen!
Did you have the May $18 calls
Do you believe that no naked short selling occurs at this time, with the new regulations in place?
I can only hope she is adamant about doing her job. It was presented well, short and to the point. I condensed it from what you received, and stated FACTS that no one could overlook.
No accusations of any kind, just pointed out the obvious, and went on to say if this is flawed, the rest probably are also.
I put some serious thought and time in it.
Okay obviously my broker is missing something. I thought something was odd with the last filing missing from where it should have been. I didn’t go to EDGAR
I Truly Hope Pernock has a funding plan that does not dilute shareholders once again. They have paid enough already imho.
I did'nt see any NT10Q filed? My broker shows last 10-Q filed for FCSC was Aug 15 2011? I don't know whats up with this. ????
Good Question
Flash
BTW, I received a Confirmed Receipt Last Monday at 1300. No doubt in my mind they are looking into the matter.
I agree, but I have not seen that realm breached, not that it will not. Best for those that post those accounts just cut/paste content information and leave out the IP address. IMHO
Just speaking of what has actually transpired the last 2 times this subject has been brought up at this board.
Honestly, I’m amazed that the Hedge funds take these posts with real compassion. Never seen an out of place question. Yea, they are human in the end ….
If you doubt me just read them.
I assure you they won’t let the payroll go dry. He will come up with something. What I can only go by what he stated in the Conference Call. I took the man at his word.
I hope he has sold the company, but I suspect another dilution is near, and a partner (deal ?) for future uses.
If a deal has occured we will get a new read on his skills as a CEO? I have my doubts, but will wait and see what transpires.
We will know soon.
The clock is ticking, and the burn rate continues.
I thought it was odd that the CEO did not want his salery revealed from the last 10K I read.
BOD
thesaud'
PDUFA date for Ridaforolimus is June 12, 2012, according to the FDA calendar below. My guess would be, this will be the last time Ariad/ the Harve speaks about Ridaforolimus unless it turns a profit for ARIA sometime in the future.
Merck bought and paid for this drug and nearly owns it outright from my point of view.
H. Burger is just compiling with the fine print of their contract at this point.
Just my .02 on Rida at this point in time.
http://www.biopharmcatalyst.com/fda-calendar/
III
What’s your thoughts on NAVB? Held since before Mark Skerkil slammed them with those back to back articles. Still underwater but PDUFA Sept 10. I think they get approved. Looking for 5 plus, I have done a lot of DD on this one. Added again at just over 3 to lower PPS average.
Doesn’t look like as many Starched Shirts at this board as the other one. LOL
IIIverson
Thank you for stepping up to do the moderators job!
BOD
Thanks iandy
Good factual information!
If you have combined future revenue of Ponatinib and 113 of 4-5 Billion...???113?
Let’s see Pona come to fruition first! Then I will dream,,,,
This secinaro is to early.
If Pona passes FDA ...
Then we dream
.Great post Dreamer. Much better than all the post whining about Iverson just to get to this one! What a waste of my time. I understand Iverson; he’s been here from before the 3's.... And I have grown to enjoy his post! Unlike some that continue to bitch? I suspect a transplants?
I thought when Pona was made available to most via CU, this drug is doing well. Just a matter of time.
BTW the Golden Cross took Ariad on the chart from low 16/s to a new 52 week high over 17. What were you expecting?
His chart proved correct.
I do understand the argument that many make about charts, they show past performance which is partially true…………. But I admit, III called it well in advance and it came to pass within the date predicted.
It has been brought to her attention. In their hands now.
Done Deal, per our conversation on Friday.
Flash
I won’t disagree with any word you stated.
My response was answering exiums post specifically.
Monday is the start of a new week.
BOD
Quote I'm very upset at how Dean was complaining about money issues while sporting a new haircut and a watch the size of the moon.
To be totally honest here, I did not even notice deans watch or his new hair cut. What was obvious to me was Dean appears to be having a lot of stress in his life recently. He looks worn out physically and sounded worn out mentally. But Dean knew when he took this company public what the risk were.
After listening to the MTV before daylight this morning, my work day starts very early, I felt Dean was very honest on the topics he covered in MTV interview. A few like Mike N. and Chris S. were completely unexpected. I also noted he did not address where the 38 million missing shares that he owned went? But, he only had a limited amount of time On Air. He could not address every issue could he? There seems to be many at this time.
I plan to view it again this weekend in case I missed something. It appears that funding to go forward could be a problem and the FDA package could be submitted as late as this Fall.
In the end I felt sorry for Dean. He looks like he is not sleeping well at night. He had circles under his eyes. In the end, Dean and the shareholders both knew what they were getting into.
BuyOnDips
I DO. Still watching, funding is a serious issue right now. They need more than a few million. With the PPS where it is dilution would be serious also.
YES, and it was an odd number of votes in the 10's of thousands. You will get a PM during Happy Hour with the details. It’s nearly mathematically impossible for someone to vote exactly the opposite as I did and the numbers come out like they are filled with the SEC.
Hello Dodger Blue
I do know for a fact the Shareholder vote numbers are inaccurate. The first set as well as the second set recently published in the last 8K. You wonder how I know this, because of the way I voted! On the issue of the BOD and the 3 names listed. I voted against one and for the other two. Look at both filings in Flashes post. They reflect 14,189.473 votes against for all three. I assure you my number of votes would easily show up. They don’t. If this is inaccurate, the entire vote count is!
The shareholder votes were either not counted at all or not counted accurately. I don’t know if these inaccuracies could get anyone jail time or not. That’s up to the SEC and the courts.
Let me guess, Dean's taking a line from the politicians. We found some absentee ballots? This is unbelievable What next?
BTH great post.
Thats why I have always read your post. You call it as it is, good or bad!
Ariad is a PIG
Oink